Product Description: Vilzemetkib (compound I) is a c-Met kinase inhibitor that can be used to inhibit neurofibromatosis type I[1].
Applications: Cancer-Kinase/protease
Formula: C36H36F2N4O5
References: [1]Use of compound as c-Met kinase inhibitor for treatment of neurofibromatosis type I. World Intellectual Property Organization, WO2022268158 A1 2022-12-29.